Blog Large Image Simple

New summer menus available from 12th Sept.

A new drug discovery and development company is taking root in Madison, and it will prevent more than a dozen skilled scientists here from losing their jobs. Nimble Therapeutics formed in April, spun out of Roche Sequencing Solutions, originally NimbleGen Systems, which is slated to close by...

To Bill Murphy and the other leaders of the Forward BIO Initiative, Wisconsin possesses all the elements to become a hub of biomanufacturing in the United States, the Midwest’s version of Boston or San Francisco in this rapidly expanding industry. “Our established, statewide excellence in research, technology development and...

Cardiovascular disease is a major cause of death worldwide, and treating it isn’t easy.  The disease wreaks havoc on patients’ blood vessels and can require complex bypass surgery. Scientists at the Morgridge Institute for Research are working toward a dream of creating artery banks — similar...

Could a blood cell type responsible for scarring and diseases such as pulmonary fibrosis be repurposed to help engineer healthy tissue? A new study by a University of Wisconsin School of Medicine and Public Health researcher shows that someday, fibrocytes may be used for regenerative therapies...

By Aaron Olver- May 7, 2019 Olver is managing director of University Research Park in Madison and a member of the board of directors for the Wisconsin Technology Council, which is headquartered in URP. By this time in 2020, University Research Park’s footprint, the portfolio of labs and...

Exact Sciences Corp. hasn’t finished building its second big laboratory building to process Cologuard tests for colorectal cancer but the Madison cancer diagnostics company already is planning for lab No. 3. And, in an unrelated move, Exact’s stock price topped $100 per share this week for...

Despite the wage gap not being closed in its entirety, women are thriving professionally, and increasingly so. According to new research published by SmartAsset, women are becoming more successful across the board, but there are a few cities in particular that stand out. The organization made...

- Expanded state-of-the-art facility provides capacity for clinical and commercial development of StrataGraft, if approved - Investment marks Mallinckrodt's continued commitment to clinical development and manufacturing in the Madison community STAINES-UPON-THAMES, United Kingdom, April 24, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical...